BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29095735)

  • 1. Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation.
    Aburjania N; Ertmer BM; Farid S; Berg M; Nienaber JJC; Tchantchaleishvili V; Stulak JM; Baddour LM; Sohail MR
    ASAIO J; 2018; 64(6):735-740. PubMed ID: 29095735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus multi-drug antimicrobial surgical infection prophylaxis for left ventricular assist devices: A systematic review and meta-analysis.
    Patel S; Choi JH; Moncho Escrivá E; Rizvi SSA; Maynes EJ; Samuels LE; Luc JGY; Morris RJ; Massey HT; Tchantchaleishvili V; Aburjania N
    Artif Organs; 2019 Jul; 43(7):E124-E138. PubMed ID: 30810232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical infection prophylaxis for left ventricular assist device implantation.
    Walker PC; DePestel DD; Miles NA; Malani PN
    J Card Surg; 2011 Jul; 26(4):440-3. PubMed ID: 21554393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
    Mourad A; Arif S; Bishawi M; Milano C; Miller RA; Maskarinec SA
    J Card Surg; 2020 Oct; 35(10):2672-2678. PubMed ID: 32678965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
    Allen L; Bartash R; Minamoto GY; Cowman K; Patel S; Vukelic S; Nnani DU; Fauvel D; Guo Y
    Transpl Infect Dis; 2022 Oct; 24(5):e13900. PubMed ID: 35785460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
    Jennings DL; Chopra A; Chambers R; Morgan JA
    Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and prognostic impact of left ventricular assist device-associated infections.
    Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
    Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.
    Cho SM; Moazami N; Katz S; Bhimraj A; Shrestha NK; Frontera JA
    Neurocrit Care; 2019 Aug; 31(1):72-80. PubMed ID: 30644037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device.
    Hieda M; Sata M; Seguchi O; Yanase M; Murata Y; Sato T; Sunami H; Nakajima S; Watanabe T; Hori Y; Wada K; Hata H; Fujita T; Kobayashi J; Nakatani T
    Transplant Proc; 2014 Apr; 46(3):907-10. PubMed ID: 24767378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Galand V; Flécher E; Auffret V; Boulé S; Vincentelli A; Dambrin C; Mondoly P; Sacher F; Nubret K; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Verdonk C; Ghodbane W; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Radu C; Pierre B; Bourguignon T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Verhoye JP; Leclercq C; Martins RP;
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1166-1175. PubMed ID: 30236390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device-related infections: does the time of onset matter?
    Lehnert AL; Hart A; Brouse SD; Charnigo RJ; Branam S; Guglin ME
    J Artif Organs; 2019 Jun; 22(2):98-103. PubMed ID: 30386926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.